Carol Prives
| Carol Prives | |
|---|---|
| Alma mater | |
| Scientific career | |
| Institutions | |
Carol L. Prives is the Da Costa Professor of Biological Sciences at Columbia University.[1] She is known for her work in the characterization of p53, an important tumor suppressor protein frequently mutated in cancer.
Prives received her BS and PhD from McGill University, doing research in the lab of Juda Hirsch Quastel.[2] She did postdoctoral fellowships at Albert Einstein College of Medicine and the Weizmann Institute.
Prives has served as Chair of the Experimental Virology and the Cell and Molecular Pathology Study Sections of the NIH. She has been a member of the Scientific Advisory Boards of the Dana-Farber Cancer Center, the Memorial Sloan Kettering Cancer Center, the Massachusetts General Cancer Center, and the National Cancer Institute.[1]
Awards
- 1996 NIH MERIT Award
- 2000 Elected Fellow, American Academy of Arts and Sciences
- 2001 Elected Fellow, American Academy of Microbiology
- 2005 Elected Member, Institute of Medicine
- 2008 Elected Member, National Academy of Sciences, Washington, DC[3]
- 2009 Rosalind E. Franklin Award for Women in Science, National Cancer Institute
- 2010 Paul Janssen Prize in Biotechnology and Medicine, Center for Advanced Biotechnology and Medicine
- 2011 AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship[4]
- 2015 Elected Fellow, AACR Academy
References
- 1 2 "Carol L. Prives, PhD - AACR International". www.aacrcanada.ca.
- ↑ "Carol L. Prives Ph.D.: Executive Profile & Biography - Bloomberg". www.bloomberg.com.
- ↑ http://www.nasonline.org, National Academy of Sciences -. "Carol Prives". www.nasonline.org.
- ↑ "Carol L. Prives, PhD".